Shire investors should snap up offer

Share This:

Shire was London’s top gainer after it rejected an approach by AbbVie of Chicago, the latest dealmaking attempt in the pharmaceutical industry. Lex’s Lucy Colback and Robert Armstrong discuss whether the offer undervalued Shire, as the Dublin-based company claims.

For more video content from the Financial Times, visit

Subscribe to the Financial Times on YouTube;

View at DailyMotion

READ  The Website Investor: The Guide to Buying an Online Website Business for Passive Income Online
Previous Blockchain: Three ways to enhance the social media ecosystem
Next Euro Plunges To 1.16 Handle After Draghi 'Dovishly' Signals End Of QE